2022

2021

Filed for a new utility patent on central nervous system disorders
Filed for 2 BBB penetration platform BIM Technology patents
Applied for 2 new polycrystalline patents
Phase II clinical trial for head and neck cancer-CRIOM approved by the Ministry of Food and Drug Safety (multinational clinical trial)
Phase II clinical trial for hematopoietic stem cell-CRIOM approved by the Ministry of Food and Drug Safety
Raised KRW 27.5 billion in Series B investment (11 institutional investors)
Phase II clinical trial for head and neck cancer-CRIOM approved by the U.S. FDA (multinational clinical trial)

2020

Completed cGMP manufacturing of the clinically developed substance (MIT-001)
Introduced a patent for a compound that prevents or treats mucositis (Catholic University Industry-University Cooperation Foundation)
Registered as R&D service business

2019

2018

Model MIT-002 - Hepatic Fibrosis